These results demonstrate that the effect of CCL21/CCR7 on cell proliferation and upregulation of cyclin A, cyclin B1, and CDK1 may occur via the ERK pathway in human NSCLC cells. Here, CCL21 is linked to non-small cell lung carcinoma.